YD Bio Limited (YDES)

NGM – Real Time Price. Currency in USD

5.19

-0.12 (-2.26%)

At close: May 12, 2026, 4:00 PM EDT

Stock details

Previous close: 5.31$
Day's range: 5.21 - 5.31$
52-week range: 4.73 - 25$
Volume: 2 813
Average volume: 5 319
Beta: 1.17
EPS (TTM): N/A
PE ratio (TTM): N/A
Forward P/E: N/A
Market cap: 374 468 430
Shares outstanding: 70 521 362
Dividend yield: N/A
Next earnings date: N/A
Sector: Healthcare
Industry: Biotechnology

About the company

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

CEO: Ethan Shen
Country: Taiwan
IPO Date
Employees: 0
Fiscal Year End: January - December
Website: https://www.ydesgroup.com

Revenue Breakdown

Medical and Other Related Products / 100.00%

News

No Data

There are no news for this stock.

Chart: YDES

Loading Chart...

Overall Score

1.4 / 1014%

Financial Strength

2.8

Profitability

Effectiveness

Growth

2.2

Forecast

Valuation

1.3

Dividend

Economic Moat

Octagon View

Strength & Weakness

Cash reserves $0.0 barely cover the upcoming debt maturities $0.0

Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity

Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage

The company has no interest-bearing debt, showcasing excellent financial strength

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	N/A	6.05	1.0
Quick ratio	N/A	5.63	1.0
Debt to Equity	N/A	0.30	1.0
Debt to Assets	N/A	1.04	1.0
Interest coverage	N/A	-16.91	10
Weighted average score			2.8

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	2022	2023	2024	2025	TTM
Total Revenue	N/A	N/A	510K	597K	N/A
Gross Profit	N/A	N/A	51K	-42K	N/A
Operating Income	-2M	-2M	-1M	-5M	-743K
Net Income	4M	-3M	-1M	-8M	-6M
EBITDA	-2M	-2M	-1M	-5M	-743K

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	N/A	-11.73	1.0
Operating margin %	N/A	-24.60	1.0
Net margin %	N/A	-172.20	1.0
EBITDA margin %	N/A	-201.27	1.0
Cash flow margin %	N/A	-156.39	1.0
Weighted average score			1.0

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	-67.68	-57.97	1.0
ROE	N/A	-63.56	1.0
ROIC	N/A	-42.57	1.0
ROCE	-43.44	-71.10	1.0
Weighted average score			1.0

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	N/A	N/A	1.0
Next quarter	N/A	N/A	1.0
Current year	N/A	N/A	1.0
Next year	N/A	N/A	1.0
Weighted average score			1.0

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	N/A	N/A	N/A	N/A	1.0
Y/Y	N/A	N/A	N/A	N/A	1.0
3y average	671.65	-203.8	N/A	-150.13	3.3
5y average	802.59	-44.97	N/A	-192.17	3.3
Weighted average score					2.2

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	N/A	-5.25	1.0
PEG (5yr expected)	N/A	0.27	1.0
P/S	610.85	64.66	1.6
P/B	66.53	2.96	1.6
Weighted average score			1.3

DCF Model

DCF Model PeriodN/A

Discount rateN/A

Perpetual growth rateN/A

Revenue 5 year CAGRN/A

FCF 5 year CAGRN/A

Fair valueN/A

Stock price5.31$

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	0.00	N/A	1.0
Payout ratio	0.00	N/A	1.0
5-year dividend growth rate	N/A	N/A	1.0
Years of dividend increase	N/A	N/A	1.0
Weighted average score			1.0

Fair Value

$1

UndervaluedStock priceOvervalued

$5.31

Economic Moat

NAME	SCALE	SCORE
Market share	None	1.0
Intangible assets	None	1.0
Switching costs	None	1.0
Network effect	None	1.0
Economies of scale	None	1.0
Weighted average score		1.0

About the company

CEO

Ethan Shen

Country

Taiwan

IPO Date

Employees

Fiscal Year End

January - December

Website

https://www.ydesgroup.com

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

N/A

6.05

1.0

Quick ratio

N/A

5.63

1.0

Debt to Equity

N/A

0.30

1.0

Debt to Assets

N/A

1.04

1.0

Interest coverage

N/A

-16.91

Weighted average score

2.8

METRIC

2022

2023

2024

2025

TTM

Total Revenue

N/A

510K

597K

N/A

Gross Profit

N/A

51K

-42K

N/A

Operating Income

-2M

-1M

-5M

-743K

Net Income

-3M

-1M

-8M

-6M

EBITDA

-2M

-1M

-5M

-743K

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

N/A

-11.73

1.0

Operating margin %

N/A

-24.60

1.0

Net margin %

N/A

-172.20

1.0

EBITDA margin %

N/A

-201.27

1.0

Cash flow margin %

N/A

-156.39

1.0

Weighted average score

1.0

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

-67.68

-57.97

1.0

ROE

N/A

-63.56

1.0

ROIC

N/A

-42.57

1.0

ROCE

-43.44

-71.10

1.0

Weighted average score

1.0

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

N/A

1.0

Next quarter

N/A

1.0

Current year

N/A

1.0

Next year

N/A

1.0

Weighted average score

1.0

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

N/A

1.0

Y/Y

N/A

1.0

3y average

671.65

-203.8

N/A

-150.13

3.3

5y average

802.59

-44.97

N/A

-192.17

3.3

Weighted average score

2.2

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

N/A

-5.25

1.0

PEG (5yr expected)

N/A

0.27

1.0

P/S

610.85

64.66

1.6

P/B

66.53

2.96

1.6

Weighted average score

1.3

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

0.00

N/A

1.0

Payout ratio

0.00

N/A

1.0

5-year dividend growth rate

N/A

1.0

Years of dividend increase

N/A

1.0

Weighted average score

1.0

NAME

SCALE

SCORE

Market share

None

1.0

Intangible assets

None

1.0

Switching costs

None

1.0

Network effect

None

1.0

Economies of scale

None

1.0

Weighted average score

1.0

Search stocks

YD Bio Limited (YDES)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

YD Bio Limited (YDES)

Stock details

About the company

Revenue Breakdown

News

Chart: YDES

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$1

$5.31

Economic Moat

Stock details

About the company

Revenue Breakdown

News

Chart: YDES

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$1

$5.31

Economic Moat